Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Enovis Corporation

Brace is involved in the insurance market, focusing on new and niche risks, offering underwriting services and support to entrepreneurial partners. They have a multi-line approach and provide analytical insights to their partners.

Brace

DePuy Synthes is a medical technology company that focuses on innovations in orthopaedic surgery, support, and education for providers. It is part of the Johnson & Johnson MedTech group.

DePuy Synthes

Lincoln Electric Europe specializes in manufacturing and selling welding and cutting equipment, filler metals, and automated solutions.

Lincoln Electric Europe

Enovis is a medical technology company focused on developing clinically differentiated therapeutic solutions that generate measurably better patient outcomes and transform workflows.

Metric
Company Name	Enovis Corporation	Brace	DePuy Synthes	Lincoln Electric Europe
Symbol	ENOV
MSH ID	COM:ENOVIS	COM:BRACEUW	COM:DEPUYSYNTHES	COM:LINCOLNELECTRICEUROPE
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Industrials	Financial Services & Finance	Healthcare & Health Services	Capital Goods & Industrials
Industry	Industrial - Machinery	Insurance	Medical Technology	Manufacturing
Country	US	GB	US	GB
Stage		Series B
Employee Count	6.55K			5.00K
Website	enovis.com	braceuw.com	depuysynthes.com	lincolnelectriceurope.com
LinkedIn				lincoln-electric-europe
Founders

Metric
Market Cap	2.40B
Enterprise Value
Monthly Web Traffic		2.29K	654.91K
Web Traffic Growth		-0.20	0.57
Valuation
Raised Capital		15.70M

Metric
Revenue	1.71B
Revenue (LTM)
Revenue (NTM)
Gross Profit	990.78M
EBITDA	194.39M
Operating Income	-65.71M
Net Income	-33.26M
EPS	-0.61
Diluted EPS	-0.61
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.58
Operating Profit Margin	-0.04
EBITDA Margin	0.11
Net Profit Margin	-0.02
Return on Equity	-0.01
Return on Assets	-0.01
Return on Capital Employed	-0.02

COM:ENOVIS

Enovis

Last Close

46.17

22/11 21:00

Market Cap

2.40B

Beta: -

Volume Today

604.68K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-35.50
P/B Ratio	0.93
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.92
EV Multiple	50.02

Metric
Days Sales Outstanding	60.88
Days Payables Outstanding	64.95
Days Inventory Outstanding	280.07
Operating Cycle	356.60
Cash Conversion Cycle	282.17
Asset Turnover	0.38

Metric
Operating Cash Flow	134.99M
Free Cash Flow	12.77M
Cash Flow to Debt	0.25
Operating Cash Flow/Sales	0.08
Free Cash Flow Yield	-0.03

Metric
Cash & Equivalents	36.19M
Accounts Receivable	-16.32M
Inventory	468.83M
Goodwill	2.06B
Debt to Capitalization	0.30
Debt to Assets	0.11
Current Ratio	2.40
Quick Ratio	1.08

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.04
SG&A to Revenue